2004, Clinical Trials, Policy and Safety

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2004

Clinical Trials

Policy

Safety

MAPS Is 36 Years Old – Doblin Provides Precis Timeline of the Organization

Cannabis Law Report

APRIL 8, 2022

This year, we are completing the second Phase 3 clinical trial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. MAPS completed the first Phase 1 safety study with MDMA and resumed working on a protocol for anxiety associated with cancer.

Clinical Trials

Clinical Trials Therapy Research and Development DEA

Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. Framings that more often carried a negative tone were related to poor evidence and safety issues.

Research and Development

Research and Development Medicine Access Media

Medical Cannabis Brief

MAPS Is 36 Years Old – Doblin Provides Precis Timeline of the Organization

Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications

Stay Connected